Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Bullboard Posts
Comment by Righttothetopon Nov 16, 2020 1:51pm
252 Views
Post# 31907636

RE:RE:RE:RE:RE:RE:RE:RE:RE:Medipharm Labs Revenues Crater 64.5% Quarter Over Quarter To

RE:RE:RE:RE:RE:RE:RE:RE:RE:Medipharm Labs Revenues Crater 64.5% Quarter Over Quarter ToThat's pretty much it....if the BoD decides to hang it up, then we'll know all is lost.

Don't think it's dead and buried yet, but if some of the high priced directors start exiting then we'll know, as you've said.

Still think this has some chance of recovering next year when new areas come online, but it ain't sunshine and lollipops between now and then.  A miracle would be nice....:)

Starkicker wrote: We'll know when those latest board appointments pull the chute that LABS is toast. No way it recovers from this without some kind of miracle. And if by "reduced headcount" they mean $3M worth of layoffs, that's about a quarter of their staff.


Bullboard Posts